Insight, stigma, and explanatory models among patients with psychotic disorders and their caregivers: A cross-sectional exploratory study.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - Ongoing
Project Lead
Mrs. Nisha
Authors
Mrs. Sudipta Debnath, Mrs. Nisha C.K., Mrs. Jyothi , Mrs. Bindu Kumari & Bincy Bernabas
Project Status
ongoing
Project Type
Faculty